BACKGROUND: Pulmonary hypertension and right ventricular failure are major contributors to morbidity and mortality in chronic lung disease. Therefore, large animal models of pulmonary hypertension and right ventricular hypertrophy are needed to study underlying disease mechanisms and test new treatment modalities. The objective of this study was to create a low-mortality model of chronic pulmonary hypertension and right ventricular hypertrophy in sheep. METHODS: The vena cavae of nine sheep weighing 62 ± 2 (SEM) kg were injected with 0.375 g of dextran beads (sephadex) every day for 60 d. Pulmonary hemodynamics were assessed via pulmonary artery catheterization prior to the first injection and again on d 14, 28, 35, 42, 49, and 56. At the end of the experiment, the heart was removed, dissected, and weighed to determine the ratio of right ventricular mass to left ventricle plus septal mass (RV:LV+S). RESULTS: All sheep survived to 60 d. The average pulmonary artery pressure rose from 17 ± 1 mmHg at baseline to 35 ± 3 mmHg on d 56 with no significant change in cardiac output (8.7 ± 0.7 to 9.8 ± 0.7 L/min, P = 0.89). The RV:LV+S was significantly higher (0.42 ± 0.01, P < 0.001) than a historic group of untreated normal animals (0.35 ± 0.01, n = 13). CONCLUSION: This study provides a low-mortality large animal model of moderate chronic pulmonary hypertension and right ventricular hypertrophy.
BACKGROUND:Pulmonary hypertension and right ventricular failure are major contributors to morbidity and mortality in chronic lung disease. Therefore, large animal models of pulmonary hypertension and right ventricular hypertrophy are needed to study underlying disease mechanisms and test new treatment modalities. The objective of this study was to create a low-mortality model of chronic pulmonary hypertension and right ventricular hypertrophy in sheep. METHODS: The vena cavae of nine sheep weighing 62 ± 2 (SEM) kg were injected with 0.375 g of dextran beads (sephadex) every day for 60 d. Pulmonary hemodynamics were assessed via pulmonary artery catheterization prior to the first injection and again on d 14, 28, 35, 42, 49, and 56. At the end of the experiment, the heart was removed, dissected, and weighed to determine the ratio of right ventricular mass to left ventricle plus septal mass (RV:LV+S). RESULTS: All sheep survived to 60 d. The average pulmonary artery pressure rose from 17 ± 1 mmHg at baseline to 35 ± 3 mmHg on d 56 with no significant change in cardiac output (8.7 ± 0.7 to 9.8 ± 0.7 L/min, P = 0.89). The RV:LV+S was significantly higher (0.42 ± 0.01, P < 0.001) than a historic group of untreated normal animals (0.35 ± 0.01, n = 13). CONCLUSION: This study provides a low-mortality large animal model of moderate chronic pulmonary hypertension and right ventricular hypertrophy.
Authors: Hitoshi Sato; Candice M Hall; Grant W Griffith; Kent F Johnson; John W McGillicuddy; Robert H Bartlett; Keith E Cook Journal: ASAIO J Date: 2008 Jul-Aug Impact factor: 2.872
Authors: G Della Rocca; F Pugliese; M Antonini; C Coccia; L Pompei; C D Vizza; E A Rendina; C Ricci; R Cortesini Journal: Transplant Proc Date: 1997-12 Impact factor: 1.066
Authors: Maria E Campian; Maxim Hardziyenka; Martin C Michel; Hanno L Tan Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2006-09 Impact factor: 3.000
Authors: Kurt R Stenmark; Barbara Meyrick; Nazzareno Galie; Wolter J Mooi; Ivan F McMurtry Journal: Am J Physiol Lung Cell Mol Physiol Date: 2009-09-11 Impact factor: 5.464
Authors: Paul M Hassoun; Luc Mouthon; Joan A Barberà; Saadia Eddahibi; Sonia C Flores; Friedrich Grimminger; Peter Lloyd Jones; Michael L Maitland; Evangelos D Michelakis; Nicholas W Morrell; John H Newman; Marlene Rabinovitch; Ralph Schermuly; Kurt R Stenmark; Norbert F Voelkel; Jason X-J Yuan; Marc Humbert Journal: J Am Coll Cardiol Date: 2009-06-30 Impact factor: 24.094
Authors: Halina S Chkourko; Guadalupe Guerrero-Serna; Xianming Lin; Nedal Darwish; Joshua R Pohlmann; Keith E Cook; Jeffrey R Martens; Eli Rothenberg; Hassan Musa; Mario Delmar Journal: Heart Rhythm Date: 2012-03-07 Impact factor: 6.343
Authors: Fares Alghanem; Ryan P Davis; Benjamin S Bryner; Hayley R Hoffman; John Trahanas; Marie S Cornell; Alvaro Rojas-Peña; Robert H Bartlett; Ronald B Hirschl Journal: ASAIO J Date: 2015 Jul-Aug Impact factor: 2.872
Authors: Fares Alghanem; Benjamin S Bryner; Emilia M Jahangir; Uditha P Fernando; John M Trahanas; Hayley R Hoffman; Robert H Bartlett; Alvaro Rojas-Peña; Ronald B Hirschl Journal: ASAIO J Date: 2017 Mar/Apr Impact factor: 2.872
Authors: Begum Akay; Julie A Foucher; Daniele Camboni; Kelly L Koch; Ayushi Kawatra; Keith E Cook Journal: ASAIO J Date: 2012 Jul-Aug Impact factor: 2.872
Authors: Rei Ukita; Andrew Tumen; John W Stokes; Christopher Pinelli; Kelsey R Finnie; Jennifer Talackine; Nancy L Cardwell; W Kelly Wu; Yatrik Patel; Emily J Tsai; Erika B Rosenzweig; Keith E Cook; Matthew Bacchetta Journal: ASAIO J Date: 2022-02-01 Impact factor: 2.872
Authors: Rei Ukita; Yuliya Tipograf; Andrew Tumen; Rachel Donocoff; John W Stokes; Neal M Foley; Jennifer Talackine; Nancy L Cardwell; Erika B Rosenzweig; Keith E Cook; Matthew Bacchetta Journal: ASAIO J Date: 2021-01-01 Impact factor: 3.826
Authors: Jaume Aguero; Kiyotake Ishikawa; Kenneth M Fish; Nadjib Hammoudi; Lahouaria Hadri; Ana Garcia-Alvarez; Borja Ibanez; Valentin Fuster; Roger J Hajjar; Jane A Leopold Journal: PLoS One Date: 2015-04-29 Impact factor: 3.240
Authors: Rei Ukita; John W Stokes; W Kelly Wu; Jennifer Talackine; Nancy Cardwell; Yatrik Patel; Clayne Benson; Caitlin T Demarest; Erika B Rosenzweig; Keith Cook; Emily J Tsai; Matthew Bacchetta Journal: J Vis Exp Date: 2021-07-15 Impact factor: 1.424
Authors: Laura Glendinning; Steven Wright; Jolinda Pollock; Peter Tennant; David Collie; Gerry McLachlan Journal: Appl Environ Microbiol Date: 2016-05-16 Impact factor: 4.792